• Novel treatment approach coupling narrative exposure therapy with physiotherapy.
• Small detailed study with six torture survivors.
• Torture survivors suffering from high symptom loads can achieve good outcomes when working in parallel with traumas and pain.
• Individual differences between the six different cases; no treatment works for all patients.
Introduction
Torture is associated with adverse mental health consequences, such as high rates of symptoms of PTSD, depression and chronic pain, 1, 2 and low levels of functioning and quality of life. 3 A number of studies have investigated the link between pain and PTSD, including amongst torture survivors specifically. 4 Chronic pain is highly prevalent in torture survivors, 4 often co-occurs with PTSD and is associated with poorer prognosis. 1 Trauma survivors who have suffered trauma-related bodily injury have an eight-fold higher risk for developing PTSD, 5 which could potentially explain the higher incidence of chronic pain and PTSD amongst torture survivors. Defrin et al. 6 conclude that "torture survivors exhibit generalized diminished pain modulation and increased excitability. These alterations in the function of the pain system may underlie the chronic pain decades after the torture" (p549). Furthermore, pain-related fear has been found to be a predictor of chronicity of pain symptoms, 7 and PTSD is a higher risk factor for developing pain than the experience of trauma by itself. 8 PTSD has gained support as a risk factor contributing to more severe pain experience, poorer treatment outcome and greater pain-related disability. 9 A number of theoretical models explain the relationship between chronic pain, PTSD and depression. 4, 10, 11 The theoretical models and empirical studies give rise to several potential treatment implications. First, the effective treatment of PTSD could lead to a reduction of symptoms of chronic pain and depression and thus improve pain rehabilitation outcome in patients with chronic comorbid affective and pain symptoms (for a review, see reference 12). Second, PTSD and chronic pain can be treated simultaneously by targeting shared vulnerabilities 11 or through integrated treatments. 4, 11 Third, successful treatment of PTSD symptoms may lead to increased quality of life and functioning. Trauma-focused cognitive behavioral therapy (TF-CBT) is currently the best documented treatment for PTSD. 13 Recently, a Cochrane review on effective interventions for torture survivors concluded that narrative exposure therapy (NET) and TF-CBT had moderate effects on posttraumatic symptoms and distress six months after treatment, but the authors stressed the substantial limitations of the current evidence base. 14 Another recent review classified CBT and NET as promising interventions for torture survivors suffering from PTSD, depression or pain. 15 According to guidelines for physiotherapy for torture survivors, physiotherapy and psychotherapy should be implemented in parallel. 16 To our knowledge, few studies exist which investigate the effects of physiotherapy, or combined physiotherapy and psychotherapy, for torture survivors. However, Carlsson et al. 17 reviewed the effect of multimodal treatment implemented for 71% of a sample of patients at a specialized center for trauma and torture. The treatment included psychotherapy, physiotherapy, medical attention and social assistance with a mean of 35 sessions in total. No treatment effect was found for PTSD, depression or quality of life. At the 23-month follow-up, Carlsson et al. 18 found that approximately 1/3 of the participants reported reliable symptom improvement as measured by self-report.
Aims of this study
For the present study, physiotherapy was combined with NET in an effort to alleviate emotional distress and pain, as well as to increase quality of life and functioning, in survivors of torture presenting with comorbid pain and PTSD. Specific study aims were:
1. To run a preliminary evaluation of the potential efficacy of a combination treatment for torture survivors, targeting both posttraumatic symptoms and pain. 2. To highlight individual variation in response to the treatment, and discuss potential predictors, based on the reported clinically significant change and an analysis of the six case illustrations. 3. To explore and present topics for future research that may emerge from the descriptions of six therapy cases.
Method

Design
To examine the treatment effect of a combination of NET and physiotherapy for torture survivors with PTSD and pain, an A-B-design 19 with a three and six month follow-up was chosen. A case series design is deemed suitable for preliminary examinations of novel treatment approaches. The patients were divided into three different groups, where the onset time of physiotherapy varied between after the third, sixth and ninth NET session in order to examine whether there was an obvious effect of physiotherapy. Three experienced professionals were involved in the psychological assessment and NET treatment, but the assessor and therapist were independent of each other. All patients had the same physiotherapist, but were assessed by an independent physiotherapist.
Selection of Participants
The recruited patients were referred to the outpatient clinic for refugees connected to 
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treatment started. The number of traumatic experiences apart from the torture was high, with a mean of 7.83 (SD=2.86). The following case descriptions are based on data from the pre-test assessment. All patients reported substantial sleep disturbances, and all except for patient 5, had economic problems.
Attrition and Drop-out
Two patients were excluded from the project: One, because of psychotic symptoms, which at first did not seem substantial; and, another, because of poor attendance despite a proclaimed intention to continue treatment. Both patients were offered a different type of treatment.
Procedure
After the first assessment and prior to treatment onset, two baseline assessments were performed; after one and three weeks. After the baseline period, the patients engaged in approximately 20 sessions of NET (90 minutes each) and 10 sessions of physiotherapy (60 minutes each). Symptoms of PTSD and pain were assessed at the end of each session by self-report. In addition, the therapists filled out a NET process form after each session, to ensure adherence and document compliance to the NET treatment manual. There were two follow-up assessments, three and six months after treatment. Information about changes in refugee status, marital status, living condition and social activity was also collected. One item from the Brief Pain Inventory (BPI), the Numeric Rating Scale (NRS-11) and the Posttraumatic Diagnostic Scale (PDS) were administered after each treatment session, whereas all other instruments were administered prior to treatment and at the two follow-up assessments. All patients except for patient 3 had an interpreter present during the therapy sessions. Each patient had the same interpreter in all their treatment sessions.
Narrative Exposure Therapy (NET):
NET is a trauma-focused therapy that incorporates principles from prolonged exposure and testimonial therapy. 21 It was developed specifically for refugees that have experienced multiple traumatic events, such as persecution, flight and torture. NET is based on dual processing theory and aims to contextualize fragmented, traumatic memories. Usually, NET consists of eight to ten sessions, while in this study we have doubled the number of sessions due to the complexity of severe trauma symptoms and chronic pain. The first session is devoted to make a lifeline where the patient identifies and labels traumatic experiences over the course of their lives. In subsequent sessions, the patient and therapist collaboratively record and read the patient's life narrative and prolonged exposure techniques are applied for traumatic memories.
Physiotherapy: All patients received treatment by the same physiotherapist, who had several years of experience in working with refugees and torture survivors. The treatment was individually tailored according to the different needs of each patient.
Instruments ii Before treatment and at the follow-up assessments, we administered the ClinicalAdministered PTSD Scale (CAPS) to diagnose and assess severity levels of PTSD, and the Hamilton Rating Scale for Depression (HRSD) to evaluate the severity level of depression. The Norwegian Pain Association's Minimum Inventory for Pain Patients
ii Detailed descriptions of the instruments used can be provided upon request.
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(NOSF-MISS) was used to assess factors such as pain intensity (BPI), physical functioning, health-related quality of life, sleep difficulties and financial struggles. In the present study, the MINI International Neuropsychiatric Interview (MINI) was conducted to diagnose depression, to assess eventual comorbid psychiatric diagnoses, and to ensure that the patients did not meet the exclusion criteria. Socio-demographic questions were asked about variables such as age, sex, nationality, refugee status, education level, living conditions, social network and period of time in Norway.
NET Adherence and Compliance:
Adherence and compliance with the NET manual were rated through a self-report questionnaire, which the therapists completed after each session. They reported whether the therapeutic tasks in the manual were completed or not, how the patient responded to exposure, and whether time was used on other activities or to discuss current stressors.
Data Analysis
Visual analysis was chosen as it is recommended as the primary method for this type of study design, rather than the performance of statistical analyses. 22 It allows for an informal judgment of whether a clear treatment effect can be seen, and will, according to Parsonson and Baer, 23 reveal any treatment effect solid enough to be of importance for clinicians. In addition, the individual results and the extent of any clinically significant change for all six patients is reported. The raw scores are available on request, making it possible to compute effect sizes as recommended by Brossart et al. 24 
Results
The symptom progression of pain intensity and PTSD symptoms for the individual patients is presented in Figure 1 . Means and standard deviations for symptoms of PTSD, depression and pain intensity are presented in Table 1 . iii All patient names are pseudonyms. Pseudonyms were selected from amidst name registers of the patient's respective country of origin. Cross-checking was then performed to ensure that the selected pseudonym also was in use in neighboring countries, to preclude recognition based on nationality. 
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Individual results: visual analysis
What emerges from a visual analysis (see Figure 1 ) of the individual patient data is a trend characterized by decreased PTSD symptoms, but few other changes and still a persistent degree of distress after treatment. In summary, two patients (3 and 5) have reached a relatively low level of symptom severity, two (1 and 4) have had a marked improvement but still suffer considerably, while two (2 and 6) have had unremitting symptoms. For depression, most patients had apparently experienced a decrease, while two (1 and 2) seemingly endure continuous distress. Decreased pain and improved functioning can be seen for two patients (3 and 5), and deterioration for two others (1 and 6). Missing data precludes patients 2 and 4 from the analysis of the NOSF-MISS results.
Adherence Challenges
All therapists reported adherence challenges, mostly due to the patients' needs for help with current stressors or poor compliance. Adherence was evaluated as moderate for four patients (2, 3, 5 and 6) and as low for two (2 and 6).
Evaluation of the combination treatment
A visual analysis of the symptom progression during the course of the treatment for these six patients does not reveal any clear trend, and there are substantial differences between the patients. Despite the modest decrease in PTSD symptoms observed in tracking them session to session, half of the patients no longer met the criteria for a PTSD diagnosis at the three month follow-up, and two experienced clinically significant change, defined as a decrease of >2SD in CAPS total score. 33 Furthermore, this was maintained at the six-month follow-up. Regarding depression, only one patient (patient 3) was no longer diagnosed with depression at followup and only one (patient 6) achieved clinically significant change. With respect to pain experience, two patients (3 and 5) had decreased pain intensity, two had no change (1 and 4) and one (6) experienced increased pain. Patient 2 achieved a clinically significant decrease in pain intensity, when considering the symptom progression from baseline to the final sessions (see Table 1 ). In
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addition, no differences regarding startup time of the physiotherapy were observed in this study. The treatment results for pain intensity differed substantially between the patients, with some having dramatic changes and others none. Even though three out of five had clinically significant pain reduction at the first follow-up, only two of them retained these reductions three months later. In summary, as a preliminary evaluation, this novel combination treatment appears to be more effective for PTSD symptoms, and less so for pain and depression. However, this argument is highly speculative, for obvious methodological reasons.
Discussion
Variation in treatment response and potential predictors It was expected that the combination of NET and physiotherapy would potentially be a promising treatment development for torture survivors with chronic pain and PTSD. However, as this study failed to illustrate an unambiguous treatment effect on PTSD and pain symptoms, it is clearly not generalizable across different clinical cases. With this research design or actual outcomes, it cannot be concluded that the patients improved because of the treatment provided. Still, it is useful to discuss possible explanations for the differential outcome of our patients, since identifying what factors may predict the outcome is of great importance for clinicians. According to Barlow et al., in case studies, "the issue of interpreting mixed results and looking for causes of failure illustrates an important principle in replication series" (p318). 19 Failures do not necessarily indicate that a treatment fails to work, but might point to circumstances and conditions under which the treatment does not have the desired effect. 19 In our study, there are substantial differences in the extent of symptomatic improvement among the patients. In sum, two ("responders": patients 3 and 5) of the patients became much better, with great reductions in both PTSD symptoms and pain intensity. Another two ("part responders": patients 1 and 4) showed improvement with regard to PTSD but still experienced substantial distress, and no change in pain intensity. The last two ("non-responders": patients 2 and 6) did not improve. Why was the treatment more effective for the responders than for the other patients?
Applying Weathers categories, 25 the responders had lower degrees of PTSD severity prior to treatment (severe and moderate), while the other four had extreme PTSD. One possible explanation is that the treatment is more effective for less severe cases. The results might also reflect a ceiling effect, such that the treatment only has an effect up to a certain degree. Furthermore, the results may reflect a therapist effect, as the same therapist had both patients within each category. The moderate to low degree of compliance or adherence could possibly have led to reduced effect of the treatment for some of the patients. In this study, compliance was not related to symptom load, as the non-responders and responders had the same degree of compliance. Avoidance during exposure was reported in all six cases. However, compliance and adherence were evaluated as lower for the part responders compared with the other patients. In addition, the physiotherapist reported compliance challenges with the part responders, including lack of motivation. Another observation was that the therapists reported extratherapeutic stressors and low physical functioning to interfere with compliance. Thus, better identification of obstacles to compliance might lead to improved outcome for some of the patients. As noted by Silove, 26 substantial psychosocial problems
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have been associated with poorer treatment outcomes and compliance. Some opponents of trauma-focused therapy for torture survivors argue that it is too narrow and risks ignoring the many and complex issues this group struggles with. 27 In this regard, Patel 28 raises concern that this approach is medicalizing a sociopolitical problem, and the cross-cultural applicability of PTSD has been debated. 29 Thus, we acknowledge that the compliance challenges could be related to cultural or other factors that NET does not adequately address. However, avoidance is one of the core symptoms of PTSD, and a recent paper questions the validity of not offering trauma-focused therapy to refugees based on the assumption that they suffer from complex PTSD due to enduring complex trauma. 30 The non-responders differed from the others in that both were diagnosed with comorbid social phobia and lifetime panic disorder. Patient 6 additionally suffered from fibromyalgia and recurrent depressive disorder. It is possible that one or both of these disorders negatively influenced treatment outcome, in a similar way to how generalized anxiety disorder affects treatment of other anxiety disorders. 31 Both disorders can possibly lead to social avoidance or isolation, and thus hinder social support, which is indeed a factor associated with poorer mental health in refugees. 32 According to Silove, 26 current stressors might impede recovery. In fact, patient 6 (non-responder) showed improvement in PTSD early on which subsequently declined and instead was aggravated. The aggravation occurred when she received news of her mother's serious disease in her home country and worried about not being able to visit her. At about the same time she had a work-related accident which led to increased pain and reduced mobility and functioning. In addition, all patients except for patient 5 (responder) reported financial struggles related to their health problems. Three patients had fewer financial struggles at the final follow-up.
Limitations of the Study
First, using an A-B case series design and its accompanied small sample size impedes generalization to other populations. Second, the lack of a control group, only two baseline measurements and no control of eventual parallel pharmacotherapy make it difficult to assess whether the effects found are the consequence of the treatment provided and not owing to common factors, regression to the mean or spontaneous remission. Due to these and a number of other limitations our results should be interpreted with great caution.
Summary and conclusions
In this study, we have evaluated a novel treatment approach coupling narrative exposure therapy with physiotherapy for torture survivors suffering from chronic pain and PTSD. The small sample size and design precluded generalization and inferences about effect, however enabled an exploratory description of six therapies. Despite its limitations, the study is original in its aim to couple physiotherapy with NET, and demonstrates that some torture survivors who suffer high symptom loads can achieve good outcomes when working in parallel with traumas and pain. Furthermore, we have discussed the possible effect of this combination treatment, with an emphasis on individual differences between the six different cases. It highlights some of the complexities regarding assessment and treatment of torture survivors, exemplifies the point that no treatment works for all patients, and provides tentative explanations
S C I E N T I F I C A R T I C L E
as for why that might be. Our hope is that it stimulates research that will enable further refinement of rehabilitation strategies for torture survivors.
